Stephen Tyring, MD, PhD
Basic profileClinical Professor, Departments of Dermatology, Microbiology/Molecular Genetics and Internal Medicine · Center for Clinical Studies
Stephen Tyring is Clinical Professor, Departments of Dermatology, Microbiology/Molecular Genetics and Internal Medicine at Center for Clinical Studies. OpenAlex indexes 1,174 publications with 38,047 citations (h-index 74). By OpenAlex citation count, this profile ranks in the top 1% of Dermatology profiles in the FindMyKOL directory.
Overview
Updated 27 Oct 2026
Stephen Tyring, MD PHD, is Clinical Professor, Departments of Dermatology, Microbiology/Molecular Genetics and Internal Medicine at University of Texas Health Science Center at Houston (McGovern Medical School). The public record shows 634 publications with 25,345 citations (h-index 74), centered on Dermatology and Skin Diseases, Herpesvirus Infections and Treatments, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 50 companies, 3 NIH-funded awards (1989–2004).
- Most recent indexed publication: 2026 · Proceedings (Baylor University. Medical Center)
- Top research focus: Dermatology and Skin Diseases
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 50 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 299.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
Updated 27 Oct 2026
50 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202550 payments$35,677openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202542 payments$19,623openpaymentsdata.cms.gov ↗
- Galderma Laboratories, L.P.Program year202528 payments$14,841openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
27.4%Corticosteroid20.6%Triamcinolone Acetonide81%Halobetasol Propionate9%Triamcinolone acetonide7%Methylprednisolone3%Part D + Part B<11 patientsInterleukin-4 Receptor alpha Antagonist3%Dupixent Pen100%Part D≥16 patients+ 3 more classes in this area
Anti-infectives
26.8%Azole Antifungal13.7%Ketoconazole100%Part D≥136 patientsTetracycline-class Drug6.6%Doxycycline Hyclate100%Part D≥59 patients+ 3 more classes in this area
Sensory organs
15.9%Corticosteroid15.9%Clobetasol Propionate70%Desonide16%Hydrocortisone7%Betamethasone Dipropionate7%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Oct 2026
3 NIH research awards on record, funded 1989–2004 per NIH RePORTER. The latest:
- Genetic Resistance to Oncogenic Human Papillomaviruses
University of Texas Hlth Sci Ctr Houston
FY2004$69,910R03CA030730 - Genetic Resistance to Oncogenic Human Papillomaviruses
University of Texas Medical Br Galveston
FY2003$71,062R03CA030730 - ABT 606 VS ACYCLOVIR FOR TREATMENT OF HERPES ZOSTER
University of Texas Medical Br Galveston
FY2002$279,290M01RR000073
Publications
Updated 27 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinical progression of a smallpox postvaccination response.
Proceedings (Baylor University. Medical Center)
Case Report2026 - Switching to ustekinumab biosimilars for plaque psoriasis: A systematic review and meta-analysis.
Journal of the European Academy of Dermatology and Venereology
Letter2026 - A likely case of guttate psoriasis precipitated by syphilis: a novel association.
Proceedings (Baylor University. Medical Center)
Article2026 - Buffalopox: An emerging cutaneous disease in humans.
Journal of the European Academy of Dermatology and Venereology
Case Report2025
Most-cited works
by citation count (OpenAlex)- 01Secukinumab in Plaque Psoriasis — Results of Two Phase 3 TrialsArticle1,993 citations2014
- 02
- 03Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialArticle887 citations2007
- 04Recommendations for the Management of Herpes ZosterArticle866 citations2006
- 05Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisArticle828 citations2015
Network
Updated 27 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 27 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
- PhD
Medical Microbiology, Texas Tech University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗ - MBA
Rice University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗ - Board certified
Dermatology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗ - Board certified
Internal Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →practiceupdate.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermcast.live ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”